Whipplewood Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.53K Sell
25
-74
-75% -$7.66K ﹤0.01% 389
2026
Q1
$9.58K Buy
+99
New +$10.2K 0.01% 498
2025
Q3
– Sell
-99
Closed -$12.1K – 563
2025
Q2
$12.1K Buy
99
+77
+350% +$8.79K 0.01% 534
2025
Q1
$10K Sell
22
-77
-78% -$7.52K 0.01% 564
2024
Q4
$9.14K Buy
+99
New +$9.72K 0.01% 568

Other funds holding EHC

Whipplewood Advisors's EHC Position: Q2 2026 in Review

Whipplewood Advisors reduced its Encompass Health (EHC) stake by 75% in Q2 2026, selling an estimated $7.66K and leaving 25 shares worth $2.53K. The position accounts for ﹤0.01% of the portfolio, ranked #389.

Whipplewood Advisors first reported a position in EHC in Q4 2024 and has held it in 5 quarters since. The position peaked at $12.1K in Q2 2025. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Whipplewood Advisors held 25 shares of Encompass Health worth $2.53K as of Q2 2026.
  • Whipplewood Advisors sold 74 Encompass Health shares in Q2 2026, an estimated $7.66K.
  • Encompass Health made up ﹤0.01% of Whipplewood Advisors's portfolio in Q2 2026, its #389 holding.
  • Whipplewood Advisors first reported a position in Encompass Health in Q4 2024 and has held it in 5 quarters since.
  • Whipplewood Advisors's Encompass Health position peaked at $12.1K in Q2 2025.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.